
A retrospective study found dose-dense AC with pembrolizumab was feasible in TNBC, without more neutropenia or missed immunotherapy doses.
Samantha Hodges, PharmD; Katelyn Patterson, PharmD, et al.
September 8, 2026
Trending
Stay ahead in oncology
Weekly breakthroughs, expert insights, and clinical updates.
Our Insights
Articles, expert reviews, and opinion pieces from our leaders out in the field and treating populations
View More
In My Opinion
Addressing Cancer Health Disparities: The No One Left Alone Initiative
A rural South Carolina practice used structured social needs screening and financial support to reduce barriers to cancer care.
Rohan Nadkarni; Arva Patel, et al.
September 9, 2026

Patient Populations
Sandra Savaya, PharmD, BCOP; Christan Mychajlonka, PharmD, BCOP, et al.
August 13, 2026

In Your Practice
Raluca Laza, PharmD; Meredith Keisler, PharmD, BCOP, et al.
August 13, 2026
Watch Now
Neil M. Iyengar, MD; Annalise Labatut, PharmD, BCOP
August 26, 2026
Listen Now
Cancer, Clearly
—
our flagship podcast
Episode 4
August 11, 2026
Latest News
View More

Clinical Trials
Samantha Hodges, PharmD; Katelyn Patterson, PharmD, et al.
September 8, 2026
Oncology is evolving. Stay current.
Weekly breakthroughs, expert insights, and clinical updates —delivered to your inbox.











